Developing therapies for anemia and fibrosis; backed by Astellas and AstraZeneca
Industry: Health Care
First Day Return: +22.2%
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 10/01/2014 |
Offer Price | $18.00 |
Price Range $16.00 - $19.00 | |
Offer Shares (mm) | 8.1 |
Deal Size ($mm) | $146 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | 11/13/2014 |
Offer Price | IPO Intelligence Only |
Price Range | IPO Intelligence Only |
Offer Shares (mm) | IPO Intelligence Only |
Deal Size ($mm) | $146 |
Lock-Up Date | IPO Intelligence Only |
Street Research | IPO Intelligence Only |
Underwriters |
---|
IPO Intelligence Only |
Company Data | |
---|---|
Headquarters | San Francisco, CA, United States |
Founded | 1993 |
Employees at IPO | 337 |
Website www.FibroGen.com |